1278
R. Hassani et al. / Tetrahedron: Asymmetry 25 (2014) 1275–1279
4.2.5. (S)-5-Methyl-2-(pyrazin-2-yl)-4,5-dihydrooxazole 2e
82%; Yellow oil; [
D = +23 4 (c 0.8, CHCl3). 1H NMR (CDCl3,
4.2.12. (S)-2-(4-Chlorophenyl)-4-isopropyl-4,5-dihydrooxazole
2l
a
]
300 MHz): d = 9.41 (s, 1H), 8.77 (d, 1H; J 2.16 Hz), 8.55 (d, 1H; J
1.11 Hz), 4.08 (m, 1H), 3.69 (m, 1H), 3.38 (m, 1H), 1.29 (dd, 3H; J
6.36 Hz, J 0.99 Hz) ppm. 13C NMR (CDCl3, 75 MHz): d = 163.8,
147.3, 145.1, 144.4, 142.5, 67.3, 46.8, 21.0 ppm. TOFMS ES+ for
C8H10N3O theoretical [M+H]+: 164.0824; measured [M+H]+:
164.0821. IR-TF (KBr pellets, cmÀ1): 668.4; 1024.7; 1533.8;
1653.1; 2975.8; 3392.9.
100%; Yellow oil; 1H NMR (CDCl3, 200 MHz): d = 7.90 (d, 2H; J
8.6 Hz), 7.38 (d, 2H; J 8.6 Hz), 4.37–4.47 (m, 1H), 4.04–4.20 (m,
2H), 1.82–1.92 (m, 1H), 1.03 (d, 3H; J 6.8 Hz), 0.93 (d, 3H; J
6.8 Hz) ppm. 13C NMR (CDCl3, 75 MHz): d = 162.5, 137.3, 129.6,
128.5, 126.4, 72.6, 70.3, 32.8, 18.9, 18.0 ppm. Data in agreement
with the literature.33
4.2.13. (S)-4-Benzyl-2-(naphthalen-1-yl)-4,5-dihydrooxazole 2m
4.2.6. (S)-4-Phenyl-2-(pyridin-2-yl)-4,5-dihydrooxazole 2f
82%; Yellow oil; 1H NMR (CDCl3, 300 MHz): d = 8.75 (d, 1H; J
4.6 Hz), 8.18 (d, 1H; J 7.8 Hz), 7.78–7.85 (m, 1H), 7.29–7.47 (m,
5H), 5.42–5.52 (m, 1H), 4.87–4.96 (m, 1H), 4.40 (t, 1H; J 8.4 Hz)
ppm. Data in agreement with the literature.17
76%; Colorless oil; [a]
D = +14 1.9 (c 0.75, CHCl3). 1H NMR
(CDCl3, 200 MHz): d = 9.06 (dd, 1H; J 8.32 Hz, J 1.14 Hz), 8.10 (dd,
1H; J 7.24 Hz, J 1.28 Hz), 7.98 (d, 1H; J 8.64 Hz), 7.89 (dd, 1H; J
7.4 Hz, J 1.8 Hz), 7.54 (m, 3H), 7.31 (m, 5H), 4.78 (m, 1H), 4.44 (t,
1H, J 8.6 Hz), 4.24 (dd, 1H; J 8.48 Hz, J 7.28 Hz), 3.35 (dd, 1H; J
13.72 Hz, J 5.08 Hz), 2.90 (dd, 1H; J 13.72 Hz, J 8.48 Hz) ppm. 13C
NMR (CDCl3, 75 MHz): d = 163.9, 138.0, 133.7, 131.9, 131.1,
130.7, 129.3, 128.9, 128.5, 128.4, 127.2, 126.5, 126.4, 126.0,
124.6, 70.8, 68.6, 41.9 ppm. TOFMS ES+ for C20H18NO theoretical
[M+H]+: 288.1388; measured [M+H]+: 288.1390. IR-TF (KBr pellets,
cmÀ1): 702.3; 777.4; 996.9; 1125.4; 1191.8; 1510.9; 1642.5;
2923.4; 3060.0.
4.2.7. (S)-4-Isopropyl-2-(quinolin-2-yl)-4,5-dihydrooxazole 2g
73%; Colorless oil; 1H NMR (CDCl3, 300 MHz): d = 8.27 (d, 1H; J
8.4 Hz), 8.23 (s, 2H), 7.84 (d, 2H; J 8.1 Hz), 7.77–7.72 (m, 1H), 7.59
(t, 1H; J 7.5 Hz), 4.64–4.56 (m, 1H), 4.36–4.17 (m, 2H), 2.03–1.90
(m, 1H), 1.08 (d, 3H; J 6.8 Hz), 0.97 (d, 3H; J 6.8 Hz) ppm. Data in
agreement with the literature.31
4.2.8. (S)-2-(5-Chlorothiophen-2-yl)-4-phenyl-4,5-dihydrooxazole
4.2.14. (S)-4-Isopropyl-2-(naphthalen-1-yl)-4,5-dihydrooxazole
2h
2n
98%; Yellow oil; [a]
D = +6.4 3.1 (c 0.44, CHCl3). 1H NMR (CDCl3,
70%; Yellow oil; [a]
D = À63.6 1.9 (c 0.75, CHCl3). 1H NMR
300 MHz): d = 7.54 (d, 1H; J 3.93 Hz), 7.32 (m, 5H), 6.95 (d, 1H; J
4.02 Hz), 5.38 (dd, 1H; J 8.16 Hz, J 9.87 Hz), 4.81 (dd, 1H; J
8.46 Hz, J 9.99 Hz), 4.30 (t, 1H; J 8.23 Hz) ppm. 13C NMR (CDCl3,
75 MHz): d = 159.5, 141.7, 135.2, 130.3, 128.8, 128.3, 127.8,
127.0, 126.7, 75.3, 70.0 ppm. TOFMS ES+ for C13H11NOSCl theoret-
ical [M+H]+: 264.0250; measured [M+H]+: 264.0250. IR-TF (KBr
pellets, cmÀ1): 698.9; 1034.0; 1250.3; 1437.4; 1533.9; 1646.1;
2921.4; 3028.7.
(CDCl3, 300 MHz): d = 9.13 (d, 1H; J 8.55 Hz), 8.10 (d, 1H; J
7.23 Hz), 7.97 (d, 1H; J 5.19 Hz), 7.89 (d, 1H; J 8.13 Hz), 7.56 (m,
3H), 4.48 (dd, 1H; J 7.92 Hz, J 9 Hz), 4.25 (m, 2H), 1.98 (m, 1H),
1.14 (d, 3H ; J 6.75 Hz), 1.04 (d, 3H ; J 9.75 Hz) ppm.13C NMR
(CDCl3, 75 MHz): d = 163.3, 133.7, 131.7, 131.2, 128.9, 128.4,
127.2, 126.4, 126.0, 124.7, 124.6, 73.3, 69.3, 32.9, 19.0, 18.3 ppm.
TOFMS ES+ for C14H13N3O theoretical [M+H]+: 240.1388; measured
[M+H]+: 240.1392. IR-TF (KBr pellets, cmÀ1): 777.7; 1025.3;
1123.1; 1359.2; 1465.2; 1590.5; 1652.6; 2958.5; 3050.2.
4.2.9. (S)-2-(5-Chlorothiophen-2-yl)-4-isopropyl-4,5-dihydrooxazole
2i
4.2.15. (S)-2-(4-Fluorophenyl)-4-isopropyl-4,5-dihydrooxazole
2o
95%; Yellow oil; [
a
]
D = À36.9 4 (c 0.8, CHCl3). 1H NMR (CDCl3,
200 MHz): d = 7.57 (d, 1H; J 2.72 Hz), 6.92 (d, 1H; J 3.98 Hz), 4.45
(m, 1H), 4.16 (m, 2H), 1.89 (m, 1H), 1.02 (d, 3H; J 6.58 Hz), 0.93
(d, 3H; J 10.02 Hz) ppm. 13C NMR (CDCl3, 75 MHz): d = 158.7,
133.6, 130.7, 127.1, 71.8, 70.9, 32.5, 18.7, 17.9 ppm. TOFMS ES+
for C10H13NOSCl theoretical [M+H]+: 230.0406; measured
[M+H]+: 230.0405. IR-TF (KBr pellets, cmÀ1): 668.3; 803.1;
1042.2; 1276.4; 1436.7; 1538.3; 1646.0; 2875.3; 2965.9.
93%; Yellow oil; 1H NMR (CDCl3, 300 MHz): d = 7.92–7.98 (m,
2H), 7.04–7.27 (m, 2H), 4.35–4.42 (m, 1H), 4.04–4.15 (m, 2H),
1.81–1.87 (m, 1H), 1.02 (d, 3H; J 6.9 Hz), 0.91 (d, 3H; J 6.6 Hz)
ppm. 13C NMR (CDCl3, 75 MHz): d = 166.2, 162.9, 162.4, 130.5,
124.1, 115.4, 115.1, 72.6, 70.2, 32.8, 18.8, 18.0 ppm. Data in agree-
ment with the literature.33
4.3. General one-pot procedure for the synthesis of 4-substituted-
bis-oxazolines
4.2.10. (S)-2-Cyclopropyl-4-phenyl-4,5-dihydrooxazole 2j
67%; Yellow oil; [a]
D = +25.3 3.5 (c 0.6, CHCl3). 1H NMR (CDCl3,
200 MHz): d = 7.30 (m, 5H), 5.15 (dd, 1H; J 7.86 Hz, J 10 Hz), 4.58
(dd, 1H; J 8.34 Hz, J 10 Hz), 4.06 (t, 1H; J 8.1 Hz), 1.77 (m, 1H),
0.99 (m, 4H) ppm. 13C NMR (CDCl3, 75 MHz): d = 170.0, 142.6,
128.6, 127.4, 126.5, 74.9, 69.3, 8.5, 7.3, 7.0 ppm. TOFMS ES+ for
The synthesis of 1,2-bis((S)-4-isopropyl-4,5-dihydrooxazol-2-
yl)benzene 3 is representative. A G4 vial in a Monowave 300 vessel
was charged with phthalonitrile (37.2 mg, 0.290 mmol, 1 equiv)
C
12H14NO theoretical [M+H]+: 188.1075; measured [M+H]+:
mixed with
(L)-valinol (65.8 mg, 0.638 mmol, 2.2 equiv). The
188.1072. IR-TF (KBr pellets, cmÀ1): 701.3; 1030.4; 1172.1;
1250.1; 1405.3; 1455.3;1540.3; 1646.1.
resulting mixture was irradiated using the closed vessel mode at
150 °C for 60 min. The reaction mixture was quenched with ethyl
acetate and filtered through silica. The filtrate was dried over mag-
nesium sulfate, and concentrated by rota-evaporation under vac-
uum to give the corresponding 1,2-bis((S)-4-isopropyl-4,5-
dihydrooxazol-2-yl)benzene 1a (87 mg, 0.289 mmol, 100% yield)
as a colorless oil.
4.2.11. 1-((S)-4-Isopropyl-4,5-dihydrooxazol-2-yl)-1-
methoxyethanol 2k
75%; Yellow oil; [
a
]
D = À51.5 2.4 (c 1.18, CHCl3). 1H NMR
(CDCl3, 200 MHz): d = 5.83 (br s, 1H), 4.18 (m, 1H), 4.01 (m, 2H),
2.06 (s, 3H), 2.00 (s, 3H), 1.80 (m, 1H), 0.95 (d, 3H; J 4.38 Hz),
0.92 (d, 3H; J 2.42 Hz) ppm. 13C NMR (CDCl3, 75 MHz): d = 171.1,
170.1, 64.4, 53.4, 29.4, 20.8, 19.2, 18.5 ppm. TOFMS ES+ for
C9H18NO3 theoretical [M+H]+: 188.1287; measured [M+H]+:
188.1281. IR-TF (KBr pellets, cmÀ1): 607.0; 1037.4; 1236.0;
1539.2; 1646.1; 2967.4; 3081.9.
4.3.1. 1,2-Bis((S)-4-Isopropyl-4,5-dihydrooxazol-2-yl)benzene 1a
100%; Yellow oil; 1H NMR (CDCl3, 300 MHz): d = 7.76 (dd, 1H; J
6 Hz, J 3.6 Hz), 7.47 (dd, 1H; J 6 Hz, J 3.3 Hz), 4.34–4.43 (m, 1H),
4.05–4.14 (m, 2H), 1.86–1.92 (m, 1H), 1.05 (d, 3H; J 6.9 Hz), 0.96
(d, 3H; J 6.6 Hz) ppm. Data in agreement with literature.16